Trial Profile
Maintenance phase treatment with divalproex [valproate semisodium] for post traumatic stress disorder
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary) ; Valproic acid
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 24 Apr 2017 Status changed from completed to discontinued as the funding had expired.
- 04 Oct 2006 New trial record.